TY - CHAP
T1 - Digital PET systems
AU - van Sluis, Joyce
AU - Brouwers, Adrienne H.
AU - Boellaard, Ronald
AU - Noordzij, Walter
PY - 2022/1/1
Y1 - 2022/1/1
N2 - In the past decades, the main development in positron emission tomography (PET) technology has been detector design, specifically the adoption of solid-state technology. Conventional photomultiplier tubes have been replaced by compact detector elements commonly referred to as silicon-photomultipliers (SiPMs). At present, there are three commercially available PET/CT systems equipped with SiPM-based detectors. These so-called “digital” PET/CT systems are the Philips Vereos PET/CT (Philips Healthcare), the Siemens Biograph Vision PET/CT (Siemens Healthineers), and the GE Discovery MI PET/CT (General Electric Healthcare). This chapter on digital PET describes the technical principles regarding digital PET/CT systems, summarizes the performance characteristics for the three different systems, and reports on the resulting image quality, lesion detectability, and possibilities to reduce scan duration and/or lower the amount of 18F-FDG activity administration.
AB - In the past decades, the main development in positron emission tomography (PET) technology has been detector design, specifically the adoption of solid-state technology. Conventional photomultiplier tubes have been replaced by compact detector elements commonly referred to as silicon-photomultipliers (SiPMs). At present, there are three commercially available PET/CT systems equipped with SiPM-based detectors. These so-called “digital” PET/CT systems are the Philips Vereos PET/CT (Philips Healthcare), the Siemens Biograph Vision PET/CT (Siemens Healthineers), and the GE Discovery MI PET/CT (General Electric Healthcare). This chapter on digital PET describes the technical principles regarding digital PET/CT systems, summarizes the performance characteristics for the three different systems, and reports on the resulting image quality, lesion detectability, and possibilities to reduce scan duration and/or lower the amount of 18F-FDG activity administration.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85151190160&origin=inward
U2 - 10.1016/B978-0-12-822960-6.00131-9
DO - 10.1016/B978-0-12-822960-6.00131-9
M3 - Chapter
SN - 9780128229606
VL - 1
T3 - Nuclear Medicine and Molecular Imaging: Volume 1-4
SP - 408
EP - 415
BT - Nuclear Medicine and Molecular Imaging: Volume 1-4
PB - Elsevier
ER -